# Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye

> **NCT01661946** · PHASE3 · COMPLETED · sponsor: **Queen's University** · enrollment: 10 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** Bevacizumab
- **DRUG:** Ranibizumab

## Key facts

- **NCT ID:** NCT01661946
- **Lead sponsor:** Queen's University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2013-07
- **Final completion:** 2013-08
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01661946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01661946, "Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01661946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*